Shandong Realcan Pharmaceutical Co Ltd (002589) — Cash Flow Reinvestment Rate
Shandong Realcan Pharmaceutical Co Ltd (002589) has a Cash Flow Reinvestment Rate of 2.30x as of June 2025, reinvesting CN¥57.23 Million (capex CN¥52.73 Million plus investments CN¥4.50 Million) from operating cash flow of CN¥24.86 Million. Check Shandong Realcan Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shandong Realcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for Shandong Realcan Pharmaceutical Co Ltd across 9 annual periods. Explore 002589 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Shandong Realcan Pharmaceutical Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for Shandong Realcan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Shandong Realcan Pharmaceutical Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 10.63x | CN¥146.22 Million | CN¥13.76 Million | CN¥26.82 Million | ▲ +743.4% |
| 2024 | 1.26x | CN¥202.17 Million | CN¥160.44 Million | CN¥111.53 Million | ▼ -82.2% |
| 2023 | 7.08x | CN¥584.06 Million | CN¥82.47 Million | CN¥298.38 Million | ▲ +733.8% |
| 2022 | 0.85x | CN¥444.29 Million | CN¥523.07 Million | CN¥170.96 Million | ▼ -26.2% |
| 2021 | 1.15x | CN¥509.85 Million | CN¥442.95 Million | CN¥461.09 Million | ▼ -52.1% |
| 2020 | 2.40x | CN¥996.93 Million | CN¥414.96 Million | CN¥505.39 Million | ▲ +323.2% |
| 2019 | 0.57x | CN¥1.19 Billion | CN¥2.09 Billion | CN¥934.87 Million | ▲ +6.2% |
| 2010 | 0.53x | CN¥37.72 Million | CN¥70.56 Million | CN¥37.72 Million | ▲ +70.6% |
| 2009 | 0.31x | CN¥19.23 Million | CN¥61.38 Million | CN¥19.23 Million | — |